Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Applying to Trio Clinical Trials- Site Number : 8400106 · Houston, Texas
Answer a few short questions to share with the research team.